Search Within

Matthew David Hellmann

  1. "Biostatistics Service"
Formats
  1. Journal Article (35)
  2. Meeting Abstract (24)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (60)
  2. Department of Medicine (60)
  3. Epidemiology and Biostatistics (60)
  4. Solid Tumor Oncology Division (60)
  5. Thoracic Oncology (60)
  6. GSK Faculty (49)

More Groups

People
  1. Charles Rudin (38)
  2. Gregory Riely (28)
  3. Marc Ladanyi (28)
  4. Mark Kris (28)
  5. Ai Ni (26)
  6. Hira Rizvi (26)

More People

Years
  1. 2024 (1)
  2. 2023 (4)
  3. 2022 (5)
  4. 2021 (4)
  5. 2020 (8)
  6. 2019 (7)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Clinical Cancer Research (6)
  3. Journal of Thoracic Oncology (5)
  4. Cancer Cell (3)
  5. Journal for ImmunoTherapy of Cancer (3)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (16)
  2. American Association for Cancer Research (10)
  3. Elsevier Inc. (9)
  4. Nature Publishing Group (5)
  5. Cell Press (4)
  6. Oxford University Press (4)

More Publishers

Results (60)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab
    Journal Article

    Offin, M.; Shaverdian, N.; Rimner, A.; Lobaugh, S.; Shepherd, A. F.; Simone, C. B. 2nd; Gelblum, D. Y.; Wu, A. J.; Lee, N.; Kris, M. G.; more...
    Radiotherapy and Oncology (2020)

    Fulltext@MSK | Save
  • The genomic landscape of SMARCA4 alterations and association with patient outcomes in lung cancer
    Meeting Abstract

    Schoenfeld, A. J.; Montecalvo, J.; Namakydoust, A.; Lavery, J.; Bandlamudi, C.; Rizvi, H.; Paul, S.; Arcila, M.; Chang, J.; Sauter, J.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • Real-world evaluation of consolidative durvalumab in locally advanced non-small-cell lung cancer treated with definitive chemoradiation
    Meeting Abstract

    Shaverdian, N.; Zhang, Z.; Lobaugh, S.; Deasy, J. O.; Offin, M.; Preeshagul, I.; Hellmann, M. D.; Chaft, J.; Shepherd, A. F.; Gelblum, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes
    Journal Article

    Offin, M.; Chan, J. M.; Tenet, M.; Rizvi, H. A.; Shen, R.; Riely, G. J.; Rekhtman, N.; Daneshbod, Y.; Quintanal-Villalonga, A.; Penson, A.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers
    Journal Article

    Sabari, J. K.; Offin, M.; Stephens, D.; Ni, A.; Lee, A.; Pavlakis, N.; Clarke, S.; Diakos, C. I.; Datta, S.; Tandon, N.; more...
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save
  • Immunophenotype and response to immunotherapy of RET-rearranged lung cancers
    Journal Article

    Offin, M.; Guo, R.; Wu, S. L.; Sabari, J.; Land, J. D.; Ni, A.; Montecalvo, J.; Halpenny, D. F.; Buie, L. W.; Pak, T.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Harnessing clinical sequencing data for survival stratification of patients with metastatic lung adenocarcinomas
    Journal Article

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M.; Arbour, K. C.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of EGFR-tyrosine kinase inhibitors in patients with EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez-Vega, F.; Li, B. T.; Drilon, A.; Kris, M. G.; Rudin, C. M.; Schultz, N.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)
    Meeting Abstract

    Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save